What are the recommended medications and treatments for insomnia in adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Insomnia in Adolescents

Behavioral and educational interventions should be the first-line treatment for insomnia in adolescents, with pharmacologic therapy considered only in specific situations when behavioral approaches are not feasible or when symptoms have reached a crisis point. 1

Assessment and Screening

  • All adolescents with sleep difficulties should be screened for insomnia using targeted questions about sleep onset, sleep maintenance, sleep quality, and daytime functioning 1
  • Evaluation should include assessment of potential medical contributors to insomnia, including gastrointestinal disorders, epilepsy, pain, nutritional issues, and other sleep disorders such as sleep-disordered breathing 1
  • Psychiatric conditions such as anxiety, depression, and bipolar disorder should be considered as they may contribute to insomnia 1
  • A careful review of current medications should be performed as many can contribute to insomnia 1

First-Line Treatment: Behavioral and Educational Interventions

  • Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment for adolescents with insomnia 1, 2
  • CBT-I techniques for adolescents include:
    • Sleep restriction (bedtime shifts)
    • Stimulus control
    • Cognitive therapy (thought challenging)
    • Sleep hygiene education
    • Relaxation techniques 2, 3
  • The integration of parents in the treatment process is highly recommended, especially for younger adolescents 2
  • Educational approaches should include:
    • Promotion of good sleep habits
    • Assessment of habits that may interfere with sleep
    • Implementation of consistent bedtime routines
    • Visual supports and schedules when appropriate 1
  • Internet-delivered CBT-I has shown promise for adolescents with insomnia comorbid to psychiatric conditions, with improvements in both sleep and psychiatric symptoms 4

Pharmacologic Treatment (Second-Line)

Pharmacologic therapy may be indicated in specific situations when:

  • Behavioral approaches are not feasible
  • The intensity of symptoms has reached a crisis point
  • Behavioral interventions have been unsuccessful 1

When pharmacologic treatment is necessary:

  • Melatonin may be considered for adolescents with insomnia, though evidence for its use as a primary treatment for insomnia is limited 5
  • Short-intermediate acting benzodiazepine receptor agonists may be considered in specific cases, but should be used with caution in adolescents 1
  • Any pharmacologic treatment should be supplemented with behavioral and cognitive therapies whenever possible 1

Treatment Monitoring and Follow-up

  • Sleep diary data should be collected prior to and during the course of active treatment 1
  • Clinical reassessment should occur every few weeks until the insomnia appears stable or resolved 1
  • When a single treatment has been ineffective, other behavioral therapies, pharmacological therapies, combined therapies, or reevaluation for occult comorbid disorders should be considered 1

Important Considerations

  • The efficacy of CBT-I has been demonstrated across various populations, including adolescents 6, 7
  • Face-to-face treatments of at least four sessions appear to be more effective than self-help interventions or briefer interventions 6
  • Sleep hygiene alone is insufficient for treating chronic insomnia and should be used in combination with other therapies 1
  • The choice of specific pharmacological agent, when needed, should be directed by symptom pattern, treatment goals, past treatment responses, patient preference, comorbid conditions, and potential side effects 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.